Tessera
Folgen

Sedona Sweeney

@sedonasweeney.bsky.social

Associate Professor of Health Economics @ LSHTM, focusing on patient and provider costs of long-term health shocks incl TB & HIV. Edinburgh-based.

2 Posts232 Follower393 Folgt
Global Health Economics Centre@lshtm-gheco.bsky.social · last yr.

🌍 🏦 Tomorrow @sedonasweeney.bsky.social will give a webinar with @era4tb.bsky.social & @amr-accelerator.bsky.social on TB’s global cost burden to people and health systems, and how health economics can help direct priorities for developing new TB treatments Join 👇 amr-accelerator.eu/event/combin...

COMBINE-ERA4TB Webinar on The Cost of Treating Tuberculosis - IMI AMR Accelerator

The cost of treating tuberculosis – the role of health economics in TB treatment development Join us for this webinar with health economics experts to examine TB’s global cost burden […]

amr-accelerator.eu

John Green@johngreensbluesky.bsky.social · last yr.

Just received this photo from a friend of a warehouse in Kinshasa. These are tuberculosis medications--ALREADY PAID FOR--that aren't being distributed due to the Trump Administration's stop work order. TB treatment is being interrupted in SO many patients around the world. What does that mean? (1/2)

Photograph of a warehouse in Kinshasa where unboxed tuberculosis medications are going undistributed due to the stop work order by the Trump Administration.
Finn McQuaid@cfmcquaid.bsky.social · last yr.

PhD opportunity @lshtm-tbmod.bsky.social modelling intersection of TB (world #1 infectious killer) & climate change. Do apply to be part of a great group doing impactful work! www.lshtm.ac.uk/study/fees-a... @lshtm.bsky.social @cmmid-lshtm.bsky.social @reinhouben.bsky.social @laragosce.bsky.social

2025-26 UKHSA-LSHTM PhD Scholarship | LSHTM

The London School of Hygiene and Tropical Medicine (LSHTM) is pleased to invite applications for a 3-year full-time PhD studentship, starting in September 2025, held between the Faculty of

lshtm.ac.uk

Atul Gawande@agawande.bsky.social · 2y ago

USAID being unlawfully dismantled. DOGE member has closed HQ. New tranche of workers cut off email. Staff tell me, "It is frightening being inside USAID right now. Our checks and balances failed. Congress has abdicated its responsibilities.” And Sec. Rubio has abdicated his.

Marisa Kabas@marisakabas.bsky.social · 2y ago

New — USAID staff received an email just a few minutes ago letting them know HQ would be closed to all personnel Monday. It’s likely some employees will miss the overnight email, show up and be turned away. It was sent by Gavin Kliger, one of the young guys at DOGE doing Musk’s bidding.

To all personnel: At the direction of Agency leadership, the USAID headquarters at the Ronald Reagan building in Washington, D.C. will be closed to Agency personnel on Monday, February 3, 2025. Agency personnel normally assigned to work at USAID headquarters will work remotely tomorrow, with the exception of personnel with essential on-site and building maintenance functions individually contacted by senior leadership. Further guidance will be forthcoming.
Catherine Berry (she/her)@catherineberry.bsky.social · 2y ago

BPaL/M is cost saving based on our in-trial economic evaluation of TB-Practecal, supporting modelling studies. Great collaboration with Dr Sedona Sweeney @lshtm.bsky.social and @msfsci.bsky.social. www.thelancet.com/journals/lan... #TBsky #IDsky

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

This trial-based evidence adds to consistent indications from modelling studies that BPaL-based regimens are cost-saving for both the patient and health system. Urgent implementation of BPaL-based reg...

thelancet.com

Sedona Sweeney@sedonasweeney.bsky.social · 2y ago

Amazing timing that this paper has come out just as I return to work from maternity leave! Very proud of the work that went into this, and glad it is finally out. www.sciencedirect.com/science/arti...

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

New 6-month rifampicin-resistant tuberculosis treatment regimens containing bedaquiline, pretomanid, and linezolid (BPaL) with or without moxifloxacin…

sciencedirect.com